ICD-10 Code D81.819 | Biotin-dependent carboxylase deficiency, unspecified Symptoms, Diagnosis, Billing

Biotin-dependent carboxylase deficiency, unspecified is a rare metabolic disorder caused by a deficiency of biotin, a vitamin essential for carboxylation reactions in the body. This condition can lead to various clinical manifestations, including neurological symptoms, metabolic disturbances, and skin issues. The ICD-10 Code D81.819 facilitates accurate diagnosis, documentation, and billing, ensuring proper management and reporting of this condition in healthcare settings.

What is ICD-10 Code D81.819 for Biotin-dependent carboxylase deficiency, unspecified?

ICD-10 Code D81.819 represents Biotin-dependent carboxylase deficiency, unspecified, a genetic disorder characterized by impaired biotin metabolism. This code is used when the specific type of biotin-dependent carboxylase deficiency is not specified. It is essential for clinical documentation and billing, particularly when diagnosing patients with metabolic disorders that may require specialized care and management.

ICD-10 Code D81.819 – Clinical Definition and Explanation of Biotin-dependent carboxylase deficiency, unspecified

Biotin-dependent carboxylase deficiency, unspecified is caused by mutations in genes responsible for biotin metabolism, leading to a deficiency in biotin-dependent enzymes. This condition can result in serious health issues if not addressed promptly, necessitating medical attention for diagnosis and management.

Key Clinical Features:

• Neurological symptoms such as seizures and developmental delays.
• Dermatological manifestations including dermatitis and alopecia.
• Metabolic abnormalities like lactic acidosis and hypoglycemia.
• Potential for progressive symptoms if untreated.

ICD-10 Code D81.819 for Biotin-dependent carboxylase deficiency, unspecified – SOAP Notes & Clinical Use

ICD-10 Code D81.819 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of patients with biotin-dependent carboxylase deficiency. This code aids in capturing the patient's symptoms and guiding appropriate management strategies in both acute and chronic care settings.

What Does ICD-10 Code D81.819 for Biotin-dependent carboxylase deficiency, unspecified Mean in SOAP Notes?

In SOAP notes, ICD-10 Code D81.819 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of biotin-dependent carboxylase deficiency. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code D81.819 – Biotin-dependent carboxylase deficiency, unspecified

Prompt treatment of biotin-dependent carboxylase deficiency is crucial to prevent complications. Management typically involves biotin supplementation and supportive care.

Antibiotic Therapy:

Supportive Care:

• Biotin supplementation to restore enzyme function.
• Nutritional support to address metabolic needs.
• Monitoring for neurological and dermatological symptoms.

Infection Control:

How to Document Symptoms of Biotin-dependent carboxylase deficiency, unspecified (ICD-10 D81.819) in SOAP Notes

Subjective:

• Patient reports developmental delays and seizures.
• History of skin rashes and hair loss.
• Family history of metabolic disorders.

Objective:

• Neurological examination reveals developmental delays.
• Skin examination shows dermatitis.
• Laboratory tests indicate metabolic abnormalities.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Biotin-dependent carboxylase deficiency, unspecified (ICD-10 Code D81.819)

Assessment:

• Diagnosis: Biotin-dependent carboxylase deficiency, unspecified.
• Severity: Moderate, based on clinical presentation.
• Contributing factors: Genetic predisposition and dietary insufficiency.

Plan:

• Initiate biotin supplementation (5-10 mg/day).
• Provide dietary counseling to ensure adequate biotin intake.
• Schedule follow-up appointments to monitor progress and symptoms.

Treatment & Plan Section for ICD-10 Code D81.819 – Biotin-dependent carboxylase deficiency, unspecified

• First-line treatment includes biotin supplementation.
• Nutritional management to prevent deficiencies.
• Regular monitoring of neurological and metabolic status.
• Patient education on recognizing symptoms and when to seek care.

Using ICD-10 Code D81.819 for Biotin-dependent carboxylase deficiency, unspecified in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings.
• Use the code in settings where metabolic disorders are managed.
• Align treatment plans with clinical guidelines to support billing.
• Include relevant CPT codes for services rendered.

Related ICD-10 Codes Often Used with Biotin-dependent carboxylase deficiency, unspecified

• D81.810 – Biotinidase deficiency

ICD-10 Code D81.819 in Medical Billing and Insurance for Biotin-dependent carboxylase deficiency, unspecified

ICD-10 Code D81.819 is critical in medical billing, particularly in hospital and specialty care settings for metabolic disorders.

Billing Notes:

• Document all relevant clinical findings to support the diagnosis.
• Use the code in conjunction with appropriate clinical settings.
• Ensure all chart elements are complete for accurate claims processing.

Common CPT Pairings: